 PETACH TIKVA, Israel--BUSINESS WIRE--- CANF--Can-Fite BioPharma Ltd. NYSE American: CANF TASE:CFBI, a biotechnology company with a pipeline of proprietary small molecule drugs that bind specifically to the A3 adenosine receptor A3AR, addressing cancer, liver and inflammatory diseases, announced today that Yossi Borenstein, Shizim group CEO, was elected as an External Director at the Companys recent annual general meeting. During the past 35 years, Mr. Yossi Bornstein has played key roles in th 